Bavarian Biotech Report 2011/2012 (7MB) - Bio M

CoreLab Partners Europe GmbHCROContact:Dr. Michael KerstenElisabethstr. 91D-80797 MünchenPhone: +49 (0) 89 202 444 970Fax: +49 (0) 89 202 444 979E-Mail: lschmitz@corelabpartners.comInternet: www.corelabpartners.comKeywords: Imaging Analytics, clinical trialsCoreLab Partners is an imaging core lab, managing the complete imagingsegment of clinical trials for the global pharmaceutical, biotechnology andmedical device industries. Our expertise spans Phase I through IV and allmajor therapeutic areas. We are specialized in oncology trials but also docardiovascular, musculoskeletal, CNS and medical device studies. Our radiologists,nuclear physicians and medical oncologists interpret data from allmajor modalities, including CT, MRI, X-ray, SPECT, Ultrasound, PET andPET/CT in a centralized and independent way. We assist in planning, trackingand implementation of studies and provide medical expertise, regulatoryknow-how and validated technologies.Rosenkavalierplatz 10D-81925 MünchenPhone: +49 (0) 89 9210930Fax: +49 (0) 89 913466Internet: www.covance.comCovance Clinical and PeriapprovalServices GmbHCROKeywords: Clinical Trail Management and Monitoring, Regulatory Affairs,Oncology, CNS, Pharmacology, Medical WritinCovance is one of the world's largest and most comprehensive drug developmentservices companies with more than 11,000 employees in 60 countries.Covance is the market leader in toxicology services, central laboratoryservices, discovery services, and a top global provider of Phase III clinicaltrial management services. Through its nonclinical, clinical and commercializationservices, Covance has helped pharmaceutical and biotech companiesdevelop one-third of all prescription medicines in the market today. Covance,headquartered in Princeton, New Jersey, has annual revenues greater than$2 Billion. For more information please visit www.covance.comCRELUX GmbHBIOTECH DNA/PROTEIN ANALYTICSContact:Dr. Michael SchäfferAm Klopferspitz 19aD-82152 MartinsriedPhone: +49 (0) 89 700760-170Fax: +49 (0) 89 700760-222E-Mail: schaeffer@crelux.comInternet: www.crelux.com52Keywords: 3D Structural AnalysisCRELUX specializes in tailor made protein crystallography and fragmentbased drug discovery services. The company is a professional and dedicatedservice provider for the global pharma and biotech industry. MoreoverCRELUX is the only completely independent premium crystallography providerfully owned by its founders and directors. We are advancing innovations inprotein expression to promote the availability of high quality crystallizableprotein. Our XPRESS portfolio of readily available proteins grants turnaround times of customer complex structures within a few weeks.Crystallography services from concept to high resolution complex structureare provided under individual agreements following our customer‘s needs.In addition we are offering end-to-end fragment based discovery servicesbased on our unique screening technology INTRACT.